X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES PLETHICO PHARMA JUBILANT LIFE SCIENCES/
PLETHICO PHARMA
 
P/E (TTM) x 29.3 -1.1 - View Chart
P/BV x 6.0 0.0 35,894.9% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   PLETHICO PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
PLETHICO PHARMA
Mar-14
JUBILANT LIFE SCIENCES/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs187395 47.3%   
Low Rs6531 208.0%   
Sales per share (Unadj.) Rs364.3604.4 60.3%  
Earnings per share (Unadj.) Rs6.832.5 21.1%  
Cash flow per share (Unadj.) Rs24.551.3 47.7%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.9473.6 34.8%  
Shares outstanding (eoy) m159.2834.08 467.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 98.0%   
Avg P/E ratio x18.46.6 280.4%  
P/CF ratio (eoy) x5.14.2 123.8%  
Price / Book Value ratio x0.80.5 169.7%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,0617,262 276.2%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0521,596 692.5%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,03420,598 281.7%  
Other income Rs m191386 49.3%   
Total revenues Rs m58,22420,984 277.5%   
Gross profit Rs m5,7862,818 205.4%  
Depreciation Rs m2,812642 437.8%   
Interest Rs m3,2371,593 203.2%   
Profit before tax Rs m-72969 -7.4%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696-138 -503.3%   
Profit after tax Rs m1,0901,107 98.5%  
Gross profit margin %10.013.7 72.9%  
Effective tax rate %-965.9-14.3 6,760.0%   
Net profit margin %1.95.4 35.0%  
BALANCE SHEET DATA
Current assets Rs m29,28018,877 155.1%   
Current liabilities Rs m38,91211,896 327.1%   
Net working cap to sales %-16.633.9 -49.0%  
Current ratio x0.81.6 47.4%  
Inventory Days Days8436 234.8%  
Debtors Days Days51198 25.6%  
Net fixed assets Rs m55,7129,861 565.0%   
Share capital Rs m155341 45.3%   
"Free" reserves Rs m20,96812,331 170.0%   
Net worth Rs m26,26516,139 162.7%   
Long term debt Rs m17,1694,706 364.8%   
Total assets Rs m88,60633,146 267.3%  
Interest coverage x1.01.6 60.8%   
Debt to equity ratio x0.70.3 224.2%  
Sales to assets ratio x0.70.6 105.4%   
Return on assets %4.98.1 60.0%  
Return on equity %4.26.9 60.5%  
Return on capital %11.612.3 94.1%  
Exports to sales %37.821.4 176.8%   
Imports to sales %16.515.2 108.3%   
Exports (fob) Rs m21,9334,402 498.2%   
Imports (cif) Rs m9,5673,136 305.1%   
Fx inflow Rs m22,0044,402 499.8%   
Fx outflow Rs m11,7493,184 369.0%   
Net fx Rs m10,2551,219 841.6%   
CASH FLOW
From Operations Rs m8,0262,437 329.3%  
From Investments Rs m-1,744-6,265 27.8%  
From Financial Activity Rs m-4,4472,490 -178.6%  
Net Cashflow Rs m1,834-1,337 -137.2%  

Share Holding

Indian Promoters % 45.6 82.7 55.1%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 4.3 202.3%  
FIIs % 21.2 5.5 385.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 7.5 281.3%  
Shareholders   23,815 10,665 223.3%  
Pledged promoter(s) holding % 15.9 85.7 18.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   DIVIS LABORATORIES  WOCKHARDT LTD.  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 22, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS